Point-of-care testing leads the way: article in the Parliamentary Review 2014
Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics
The cost of managing haematology patients with invasive fungal disease
The cost and tariff reimbursement of idiopathic pulmonary fibrosis in England
Treatment for stable HIV patients in England: can we save costs and improve patient care?
The cost-effectiveness of point of care tests for chlamydia and gonorrhoeae in sexual health clinics
Cost effectiveness of screening for Chlamydia trachomatis in Ireland
Costs and cost-effectiveness of different strategies for chlamydia screening and partner notification
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia?
